The Problem Nobody Anticipated
GLP-1 medications, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have transformed obesity treatment. Their effects on weight loss are real and well-documented. But a major side effect has been drawing increasing attention from researchers and clinicians: a significant proportion of the weight lost isn't fat.
Clinical studies published in 2025 and 2026 show that up to 30 to 40% of weight loss in GLP-1 patients can come from lean mass, meaning muscle. For someone trying to improve their metabolic health, losing muscle alongside fat is the least desirable outcome. It reduces basal metabolic rate, weakens the skeletal structure, and increases fall and fracture risk.
How Much Protein You Actually Need
The nutritional response to this problem is straightforward, even if it requires discipline. Recent clinical reviews recommend targeting 1.5 grams of protein per kilogram of fat-free mass daily. Not per kilogram of total body weight, but per kilogram of lean mass.
For someone weighing 90 kg with 30% body fat, that means roughly 63 kg of lean mass, and a daily protein target of about 95 grams. That's a high but achievable level with the right food choices. The challenge with GLP-1 medications is that they dramatically suppress appetite. Many users report eating far less, making it hard to hit protein targets without deliberate planning.
Why Resistance Training Isn't Optional
Nutrition alone isn't enough. Research is clear: resistance training is the most effective intervention for preserving lean mass during GLP-1 treatment. Even two sessions per week produces a measurable difference in muscle retention.
The mechanism is simple. Resistance exercise creates an anabolic signal that stimulates muscle protein synthesis even in a caloric deficit. Without that signal, the body treats muscle as an energy source when caloric intake drops rapidly.
Documented cases show that patients on semaglutide or tirzepatide who followed a structured strength program combined with adequate protein intake not only preserved but actually increased lean mass during treatment, while losing fat. That's the optimal outcome, and it's achievable.
What This Changes for Coaches
For fitness coaches, GLP-1 medications have fundamentally changed what clients need. In 2026, a growing share of clients arrive at training sessions while on GLP-1 treatment. They need something beyond calorie-burn cardio sessions.
The priority becomes muscle preservation. That means resistance-forward programming, close attention to protein intake, and monitoring energy levels, which can fluctuate with the medications. Coaches who understand this dynamic have a real competitive advantage in 2026's fitness landscape.
The good news: the fundamentals stay the same. Twice-weekly strength training and adequate protein intake is what works, medication or not. The difference with GLP-1 clients is that it's no longer an optional recommendation. It's a clinical necessity.